CoChat

Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment

Open access
Khaja, Azharuddin Sajid Syed, Toor, Salman M., El Salhat, Haytham, Faour, Issam, Ul Haq, Navid, Ali, Bassam R., Elkord, Eyad · 2017 · Oncotarget
Cited by 121

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

// Azharuddin Sajid Syed Khaja 1, 2, * , Salman M. Toor 1, 2, * , Haytham El Salhat 3, 4 , Issam Faour 4 , Navid Ul Haq 5 , Bassam R. Ali 6 , Eyad Elkord 1, 2, 7 1 Cancer Research Center, Qatar Biomedical Research Institute, College of Science and Engineering, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar 2 Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates 3 Oncology Department, Al Noor Hospital, Abu Dhabi, United Arab Emirates 4 Surgery Department, Tawam Hospital, Al Ain, United Arab Emirates 5 Pathology Department, Tawam Hospital, Al Ain, United Arab Emirates 6 Department of Pathology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates 7 Institute of Cancer Sciences, University of Manchester, Manchester, United Kingdom * These authors contributed equally to this work Correspondence to: Eyad Elkord, email: eelkord@hbku.edu.qa , eyad.elkord@manchester.ac.uk Keywords: regulatory T cells, FoxP3, helios, immune checkpoint receptors, primary breast cancer Received: February 21, 2017 Accepted: March 16, 2017 Published: March 25, 2017 ABSTRACT Immunosuppressive cells such as regulatory T cells (Tregs) have an ambiguous role in breast cancer prognosis, with studies reporting both positive and negative correlations between Treg infiltration and prognosis. This discrepancy could be due to the different immunosuppressive molecules present in these cells. In the present study, we phenotypically characterize different Treg subsets infiltrating the tumor microenvironment (TME), compared to adjacent normal tissue and peripheral blood of primary breast cancer (PBC) patients. We report that the majority of tumor-infiltrating CD4 + and CD8 + T cells have terminally exhaustive phenotype as assessed by CD39 and PD-1 expressions. We also show that Tregs are accumulated in breast TME compared to normal tissue. Further characterization of Tregs showed that these are mainly FoxP3 + Helios + and express high levels of CTLA-4 and PD-1. This preferential accumulation of FoxP3 + Helios + Treg subset with co-expression of different immune inhibitory molecules might have a negative effect on breast cancer prognosis. Taken together, our results suggest that breast tumor cells might utilize Tregs, and different suppressive pathways involving CD39, PD-1 and CTLA-4 molecules in creating an immune-subversive environment for them to survive, and a dual blockade of these immunosuppressive molecules might be considered as an effective method in breast cancer treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.16565

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

Metadata

Authors
Khaja, A. S. S., Toor, S. M., El Salhat, H., Faour, I., Ul Haq, N., Ali, B. R., & Elkord, E.
Venue
Oncotarget
Published
2017-03-25
Volume
8
Issue
20
Pages
33159-33171
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2599346721
Cited by
121
References
15
FWCI
6.07
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.